Recent Finacing
Recent Raise
PMDI commercializes Washington University Genome Institute discoveries to develop clinical genomic diagnostic tests that differentiate indolent versus aggressive early-stage prostate cancer and stratify at-risk or diagnosed patients.
Focus Areas
Total Raised
Funding round